Fairmount Funds Management LLC - KARYOPHARM THERAPEUTICS INC ownership

KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 171 filers reported holding KARYOPHARM THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 2.47 and the average weighting 0.2%.

Quarter-by-quarter ownership
Fairmount Funds Management LLC ownership history of KARYOPHARM THERAPEUTICS INC
ValueSharesWeighting
Q4 2020$10,872,000
+6.0%
702,3510.0%3.89%
-10.5%
Q3 2020$10,254,000
-17.0%
702,351
+7.7%
4.34%
-21.2%
Q2 2020$12,356,000
+14.4%
652,351
+16.0%
5.51%
-15.9%
Q1 2020$10,803,000
+40.3%
562,351
+40.0%
6.55%
+40.4%
Q4 2019$7,699,000401,6094.67%
Other shareholders
KARYOPHARM THERAPEUTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
Consonance Capital Management LP 7,180,700$137,941,00010.27%
Palo Alto Investors LP 4,299,901$82,601,0006.92%
Fairmount Funds Management LLC 562,351$10,803,0006.55%
Avoro Capital Advisors LLC 7,000,000$134,470,0004.54%
Pinz Capital Management, LP 8,820$1,694,0004.44%
Birchview Capital, LP 148,000$2,843,0002.52%
Elk Creek Partners, LLC 699,951$13,446,0002.31%
Parkman Healthcare Partners LLC 215,802$4,146,0001.92%
EAM Global Investors LLC 136,402$2,620,0001.53%
SPHERA FUNDS MANAGEMENT LTD. 550,000$10,566,0001.32%
View complete list of KARYOPHARM THERAPEUTICS INC shareholders